Sabinsa, the multi-national health science company known for providing sustainable, natural, well-researched ingredients, will make its European debut of ImmunoSpore® at Vitafoods Europe 2026, taking place May 5–7 at Fira Barcelona Gran Via in Barcelona, Spain. As the event’s Official Longevity Sponsor, Sabinsa will welcome visitors at stand 3F104 and display its longevity-focused ingredient portfolio.
ImmunoSpore® is Sabinsa’s latest innovation in immune health. It is a postbiotic derived from heat-inactivated Heyndrickxia coagulans (MTCC 5856), standardized to 15 billion spores per gram. The formulation supports a healthy intestinal barrier, promotes balanced immune signaling, and helps maintain mucosal defenses. ImmunoSpore® addresses immune resilience in the context of healthy aging, which is one of the most pressing priorities in today’s European nutraceuticals market.
Alongside ImmunoSpore®, Sabinsa will showcase additional clinically researched actives that support longevity:
- Curcumin C3 Reduct® - The first EFSA-approved tetrahydrocurcuminoid formulation derived from curcumin, offering colorless, bioactive metabolites with enhanced bioavailability and efficacy to help support antioxidant activity and overall cellular health.*
- Cirpusins® - A patented, standardized extract from the dried rhizomes of Cyperus rotundus, clinically studied to support safe, natural weight management and healthy lipid metabolism.*
- Saberry® - Derived from Emblica officinalis (amla) and standardized to 10% beta-glucogallin, this superfruit is clinically studied for its role in supporting healthy lipid and glucose metabolism, along with antioxidant activity.*
- Nigellin® - Sourced from Nigella sativa (black cumin) seeds and standardized for 5% and 20% thymoquinone, formulated to support a healthy immune response and overall wellness.*
- Shagandha® - An ashwagandha root extract standardized to 2.5% withanolides using USP methodology, designed to support stress resilience and a balanced mood.*
- Sabeet® - A standardized beetroot extract backed by two recently published studies demonstrating benefits for heart health and improved key markers of muscle quality and neuromuscular performance in postmenopausal women.*
Sabinsa invites attendees to visit the stand and connect with its European team over a barista coffee or a signature slushie. Representatives will be on hand to discuss how Sabinsa's market-oriented approach in Europe continues to provide high-quality ingredients, exceptional service, and technical sales support.
Note: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
